MONTI, GIACOMO
 Distribuzione geografica
Continente #
AS - Asia 2.378
NA - Nord America 2.359
EU - Europa 1.399
SA - Sud America 410
AF - Africa 44
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.605
Nazione #
US - Stati Uniti d'America 2.270
SG - Singapore 956
CN - Cina 695
IT - Italia 407
HK - Hong Kong 343
BR - Brasile 336
SE - Svezia 235
DE - Germania 206
VN - Vietnam 133
RU - Federazione Russa 117
GB - Regno Unito 81
FI - Finlandia 71
CA - Canada 54
IN - India 53
PL - Polonia 47
FR - Francia 45
NL - Olanda 44
AT - Austria 33
JP - Giappone 32
MX - Messico 28
TR - Turchia 28
ZA - Sudafrica 23
IE - Irlanda 22
ES - Italia 21
AR - Argentina 20
BD - Bangladesh 20
ID - Indonesia 18
PK - Pakistan 16
CZ - Repubblica Ceca 13
CO - Colombia 12
PH - Filippine 12
PE - Perù 11
AU - Australia 10
IQ - Iraq 10
LT - Lituania 9
HU - Ungheria 8
UA - Ucraina 8
CL - Cile 7
EG - Egitto 7
IR - Iran 7
PY - Paraguay 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
NO - Norvegia 6
TN - Tunisia 6
UZ - Uzbekistan 6
EC - Ecuador 5
LU - Lussemburgo 5
MY - Malesia 5
TH - Thailandia 5
TW - Taiwan 5
BE - Belgio 4
BO - Bolivia 4
IL - Israele 4
MA - Marocco 4
OM - Oman 4
UY - Uruguay 4
VE - Venezuela 4
DK - Danimarca 3
KZ - Kazakistan 3
CR - Costa Rica 2
EU - Europa 2
GR - Grecia 2
KR - Corea 2
KW - Kuwait 2
LV - Lettonia 2
MG - Madagascar 2
AZ - Azerbaigian 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
LK - Sri Lanka 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.605
Città #
Dallas 930
Singapore 484
Hong Kong 337
Ashburn 257
Shanghai 165
Beijing 154
New York 145
Milan 120
Hefei 108
Munich 80
Boardman 72
Lawrence 61
Princeton 61
Los Angeles 57
Ho Chi Minh City 44
São Paulo 42
Nuremberg 39
Warsaw 36
Helsinki 35
Denver 32
Moscow 31
Tokyo 30
Hanoi 29
Poplar 27
Brooklyn 25
Turku 23
Dublin 22
Guangzhou 22
London 20
Seattle 19
Chennai 18
Johannesburg 18
Rio de Janeiro 18
Boston 17
Santa Clara 17
Montreal 16
Stockholm 16
Ankara 15
Frankfurt am Main 15
Mexico City 15
Toronto 15
Amsterdam 14
Vienna 14
Atlanta 13
Falkenstein 13
Rome 13
Washington 13
Council Bluffs 12
Cesano Boscone 11
Jakarta 11
Manchester 11
Orem 11
Lappeenranta 10
St Petersburg 10
Belo Horizonte 9
Chicago 9
Phoenix 9
Prague 8
San Francisco 8
The Dalles 8
Turin 8
Biên Hòa 7
Hangzhou 7
Houston 7
Rho 7
Budapest 6
Gatchina 6
Geleen 6
Hải Dương 6
Istanbul 6
Kassel 6
Lima 6
New Delhi 6
Paris 6
Pune 6
Querétaro 6
Tashkent 6
Tianjin 6
Zhengzhou 6
Brasília 5
Brescia 5
Calgary 5
Campinas 5
Columbus 5
Da Nang 5
Haiphong 5
Manaus 5
Manila 5
Mumbai 5
Quanzhou 5
Rimini 5
Romagnano Sesia 5
Shenzhen 5
Vittoria 5
Volta Redonda 5
Wolfhagen 5
Wroclaw 5
Buenos Aires 4
Curitiba 4
Esch-sur-Alzette 4
Totale 4.116
Nome #
Pirfenidone to prevent fibrosis in acute respiratory distress syndrome: The PIONEER study protocol 423
A Randomized Trial of Acute Normovolemic Hemodilution in Cardiac Surgery 243
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 133
A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients 122
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 114
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 110
Mortality after surgery in Europe: A 7 day cohort study 109
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 109
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 108
Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial 107
Amino acids and the kidney; friends or foes? 98
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 97
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 95
Sex-related mortality differences in young adult septic shock patients 95
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 95
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 95
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis 91
Mastering the Sequential Organ Failure Assessment Score: Critical Choices of Score Statistic, Timing, Imputations, and Competing Risk Handling in Major Trials—A Systematic Review 85
Norepinephrine Salt Formulations and Risk of Therapeutic Error: Results of a National Survey 84
Residual lung damage following ARDS in COVID-19 ICU survivors 84
Angiotensin II infusion and markers of organ function in invasively ventilated COVID-19 patients 82
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 81
Continuous infusion versus bolus injection of furosemide in pediatric patients after cardiac surgery: A meta-analysis of randomized studies 81
Intravenous amino acids for renal protection in patients receiving temporary mechanical circulatory support: a secondary subgroup analysis of the PROTECTION study 80
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 80
High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial 79
Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design 79
Early noninvasive ventilation in general wards for acute respiratory failure: an international, multicentre, open-label, randomised trial 77
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 73
Continuous infusion versus bolus injection of furosemide in critically ill patients. A systematic review and meta-analysis 71
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies 71
Could CPAP Devices Be Used to Ventilate Cardiac Arrest Patients? A Bench Study 70
Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies 70
Effect of Remote Ischemic Preconditioning on Myocardial Injury in Noncardiac Surgery: the PRINCE Randomized Clinical Trial 69
Dexamethasone in COVID-19: does one drug fit all? 69
null 69
Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in Milan 68
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 67
Extracorporeal membrane oxygenation for prevention of barotrauma in patients with respiratory failure: A scoping review 66
Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial 65
Early progressive mobilization in intensive care unit without adjunctive personnel 65
Immunosuppressive strategies in invasively ventilated ARDS COVID-19 patients 65
Is SARS-CoV-2-induced disease a decisive factor influencing testosterone in males? Findings from a case-control ex post facto study 62
Activities of a medical emergency team twenty years after its introduction 62
Propofol and survival: a meta-analysis of randomized clinical trials 62
Predictors of Pneumothorax/Pneumomediastinum in Mechanically Ventilated COVID-19 Patients 62
Home ventilators for invasive ventilation of patients with COVID-19 61
Two months quality of life of COVID-19 invasively ventilated survivors; an Italian single-center study 61
Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock 60
2012 pandemic flu 59
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 59
Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial (Intensive Care Medicine, (2022), 48, 12, (1736-1750), 10.1007/s00134-022-06912-w) 57
Clinical aspect of sepsis: an overview 56
Percutaneous tracheostomy in COVID-19 patients: a new apneic approach 56
AED training with a 3D-printed model and a smartphone app 54
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 53
Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study 53
Microvascular lung vessels obstructive thromboinflammatory syndrome in patients with COVID-19: Insights from lung intravascular optical coherence tomography 52
Citrate anticoagulation to reduce mortality in patients needing continuous renal replacement therapy 51
The impact of non-blinding in critical care medicine trials 51
Hemodynamic Improvement in Acute Respiratory Distress Syndrome Patients After Venovenous Extracorporeal Membrane Oxygenation Implantation 50
Human protein C concentrate in pediatric septic patients 50
Non-invAsive VentIlation for early General wArd respiraTory failurE (NAVIGATE): A multicenter randomized controlled study. Protocol and statistical analysis plan 50
Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database 49
Percutaneous tracheostomy, a systematic review. 48
Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study 46
Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter randomized trial 46
Continuous infusion versus intermittent administration of meropenem in critically ill patients. A multicenter randomized double-blind trial 45
Long-term survival rate in patients with acute respiratory failure treated with noninvasive ventilation in ordinary wards 45
Dexamethasone in COVID-19: does one drug fits all? 45
Outcome of cardiac surgery in patients with low preoperative ejection fraction 44
Spinal analgesia in cardiac surgery: a meta-analysis of randomized controlled trials 42
Decreasing mortality with drotrecogin alfa in high risk septic patients A meta-analysis of randomized trials in adult patients with multiple organ failure and mortality >40% 42
Nonsurgical Strategies to Reduce Mortality in Patients Undergoing Cardiac Surgery: An Updated Consensus Process 41
Interventions affecting mortality in critically ill and perioperative patients: A systematic review of contemporary trials 41
Nerve Compression Injuries After Prolonged Prone Position Ventilation in Patients With SARS-CoV-2: A Case Series 41
PREDICTORS AND OUTCOMES OF DELIRIUM IN THE EMERGENCY DEPARTMENT IN COVID-19 PATIENTS 40
Safety and efficacy of percutaneous tracheostomy techniques in critically ill patients: a comparative meta-analysis of randomized trials 40
Vitamin D and outcomes in adult critically ill patients. A systematic review and meta-analysis of randomized trials 40
Single dilator vs. guide wire dilating forceps tracheostomy: a meta-analysis of randomised trials 40
Management of critically ill patients with coviD-19: suggestions and instructions from the coordination of intensive care units of lombardy 40
High doses proton pump inhibitors in sepsis: design of a randomized trial with in vitro experiments to search specific hallmarks in monocytes from septic patients and to characterize the mechanism of action of PPI 39
Non-invasive ventilation after cardiac surgery outside the Intensive Care Unit 39
Meropenem Administration in Critically Ill Patients With Sepsis-Reply 37
Optimizing meropenem infusion: the importance of concentration and stability 37
Human protein C concentrates in adult septic patients 37
Observed versus predicted hospital mortality in general wards patients assisted by a medical emergency team 37
Monitoring non-invasive ventilation outside the intensive care unit 37
Protective Hemodynamics: C.L.E.A.R.! 36
Towards zero perioperative mortality. 35
Preventing deaths related to percutaneous tracheostomy: safety is never too much! 35
Decision making in the democracy-based medicine era: The consensus conference process 33
Levosimendan: new indications and evidence for reduction in perioperative mortality? 33
Noninvasive Ventilation After Thoracoabdominal Aortic Surgery: A Pilot Randomized Controlled Trial 33
Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: Insights from the LUNG SAFE study 32
Death in hospital following ICU discharge: insights from the LUNG SAFE study 31
Outcome of patients with acute respiratory distress syndrome: cause of death, survival rates and long-term implications 31
The Brachiocephalic Vein as a Safe and Viable Alternative to Internal Jugular Vein for Central Venous Cannulation 31
Non-invasive ventilation, ordinary wards and medical emergency team: Maximizing effectiveness while preserving safety 30
A Multinational Randomized Trial of Mega-Dose Esomeprazole As Anti-Inflammatory Agent in Sepsis 30
Totale 6.703
Categoria #
all - tutte 38.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.923


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 19 0 5 8 0 9 1
2021/2022117 0 0 1 30 8 11 13 24 6 7 11 6
2022/2023410 142 88 26 5 15 46 16 36 14 2 8 12
2023/2024686 21 29 97 41 62 137 39 47 9 19 50 135
2024/20252.016 175 41 35 117 90 154 281 218 356 195 132 222
2025/20263.596 552 626 832 782 612 192 0 0 0 0 0 0
Totale 6.938